Zimmer Biomet (ZBH) is likely to grow in the coming quarters, backed by the implementation of meaningful strategic pillars within its Knee business. The company is benefitting from improved procedural volumes in a gradually stabilizing global musculoskeletal market. Zimmer Biomet is also bolstering its foothold in emerging markets for long-term growth opportunities, buoying optimism.Meanwhile, unfavorable solvency and an intense competitive landscape remain concerning for the company.In the past year, this ...